NF-κB (nuclear factor κB) has a pivotal role in many cellular processes, including the inflammatory and immune responses and, therefore, its activation is tightly regulated by the IKK (IκB kinase) complex and by IκBα degradation. When Shigella bacteria multiply within epithelial cells they release peptidoglycans, which are recognized by Nod1 and stimulate the NF-κB pathway, thus leading to a severe inflammatory response. Here, we show that IpaH9.8, a Shigella effector possessing E3 ligase activity, dampens the NF-κB-mediated inflammatory response to the bacterial infection in a unique way. IpaH9.8 interacts with NEMO/IKKγ and ABIN-1, a ubiquitin-binding adaptor protein, promoting ABIN-1-dependent polyubiquitylation of NEMO. Consequently, polyubiquitylated NEMO undergoes proteasome-dependent degradation, which perturbs NF-κB activation. As NEMO is essential for NF-κB activation, we propose that the polyubiquitylation and degradation of NEMO during Shigella infection is a new bacterial strategy to modulate host inflammatory responses.
. As NF-κB has a central role in the regulation of numerous genes involved in stress responses, cell proliferation and the inflammatory responses 4 , NF-κB activation is tightly regulated by the multi-protein IKK complex and the NF-κB inhibitor IκB. Upon stimulation of the IKK complex, which is composed of IKKα, IKKβ, NEMO/IKKγ and ELKS, IκB is phosphorylated by IKKα and IKKβ, polyubiquitylated and degraded by the proteasome, thereby allowing NF-κB to translocate to the nucleus and activate transcription of proinflammatory cytokines and antimicrobial peptide genes. Importantly, activation of the IKK complex is primarily dependent on modification of NEMO by Lys 63-linked polyubiquitin chains 5, 6 . During multiplication, cytoplasm-invading bacteria, such as Shigella, release PGNs and LPSs, which induce a strong inflammatory response 7 . Nevertheless, such pathogens are able to efficiently colonize the intestinal epithelium because they possess highly evolved systems that modulate the host inflammatory and immune responses 8, 9 . For example, Shigella deliver a number of effectors, including OspG, OspF and IpaH9.8 (a member of the IpaH family), into the host cell cytoplasm and nucleus through their type III secretion system (TTSS) [10] [11] [12] [13] [14] . The IpaH family is of great interest because bacterial effectors produced by mammal, fish and plant pathogens, including the Yersinia, Salmonella, Edwardsiella, Bradyrhizobium, Rhizobium and some Pseudomonas species, share several structural and functional characteristics with the members of the IpaH family, namely, their amino-terminal portions contain highly conserved leucine-rich repeats (LRR), while their conserved carboxy-terminal regions possess E3 ligase activity 15 . The crystal structure of IpaH proteins has recently been described, and based on this structure the IpaH family has been identified as a new class of E3 ubiquitin ligases found in pathogenic and symbiotic bacteria 16, 17 . Although the host target molecule(s) of the IpaH family E3 ligase activity remains unknown, in a yeast-cell system, one of the IpaH family, IpaH9.8, was shown to have activity that interferes with the pheromone response by ubiquitylation and proteasome degradation of the MAPK kinase Ste7 (ref. 15) . Furthermore, previous studies have suggested that Shigella IpaH9.8 affects NF-κB-dependent gene expression and the activity of U2AF 35 , an alternative splicing factor, and that IpaH9.8 has an important role in modulating the host inflammatory response 12, 18 . Therefore, in this study, we attempted to identify the host target protein of IpaH9.8 E3 ligase activity and to elucidate its role in Shigella infection.
The levels of IκBα and IL-8 in HeLa cells infected with Shigella strain YSH6000 (wild type) or a Shigella ΔipaH9.8 mutant were measured. IκBα levels in cells infected with ΔipaH9.8 were found to be lower than in cells infected with the wild-type strain, while IL-8 levels in cells infected with ΔipaH9.8 were higher than in cells infected with the wild-type strain (Fig. 1a) . To confirm the effect of IpaH9.8, cells carrying pNF-κB-Luc (an NF-κB-luciferase reporter plasmid) plus an IpaH9.8-expressing plasmid (pIpaH9.8) or a mock plasmid were infected with Shigella; the NF-κB activity in the presence of IpaH9.8 was found to decrease in a dose-dependent manner (Fig. 1b) . We then investigated whether the effect of IpaH9.8 was specific to the NF-κB pathway by measuring the levels of IκBα, phosphorylated-Erk and phosphorylated-JNK in HeLa/IpaH9.8-Flag cells. The results showed that the IκBα signalling pathway, but not other signalling pathways, such as the MAPK pathway, is involved in the IpaH9.8-dependent downregulation ( Supplementary  Information, Fig. S1 ). When dominant-negative (DN) forms of TRAF2, MyD88 or Nod1 were expressed in cells, MyD88-DN and Nod1-DN, but not TRAF2-DN, reduced NF-κB activity (Fig. 1c) , suggesting that IpaH9.8 preferentially targets Nod1 or TLR4 signalling. When pNF-κB As the Cys 337 residue of the IpaH family proteins, including IpaH9.8, is critical to their E3 ligase activity [15] [16] [17] , we investigated the involvement of Cys 337 in the suppression of NF-κB activation using a NF-κB reporter assay. NF-κB activation by Nod1 was reduced by IpaH9.8 in a dose-dependent manner, but not by IpaH9.8CA (E3 ligase-deficient mutant with Ala substituted for Cys 337; Fig. 1d ). HeLa cells infected with Shigella expressing IpaH9.8, but not IpaH9.8CA, showed inhibited IκBα degradation (Fig. 1e) . Similarly, the nuclear translocation of NF-κB stimulated by Shigella infection was greatly reduced in the cells expressing IpaH9.8 but not IpaH9.8CA (Fig. 1f) . These results clearly indicate that the E3 ligase activity of IpaH9.8 is critical to dampen NF-κB activation during Shigella infection.
Shigella infection
Yeast two-hybrid screening of HeLa cell and human brain cDNA libraries with IpaH9.8 as bait identified NEMO/IKKγ and ABIN-1 (A20-binding inhibitor of NF-κB) as IpaH9.8 binding partners. ABIN-1 binds to NEMO, facilitating A20-mediated removal of polyubiquitin chains from NEMO, and preventing NF-κB activation [19] [20] [21] . To confirm the interactions observed in the yeast two-hybrid screening, we performed a GST pulldown and immunoprecipitation assays (Fig. 2a, 4a ). NEMO contains two coiled-coil domains (CC1 and C2), a leucine zipper (LZ) and a C-terminal zinc finger (ZF) domain, required for correct assembly of the IKK complex. The use of NEMO truncations enabled the identification of a region (residues 347-396) between the LZ and ZF domain that is responsible for the interaction with IpaH9.8, and IpaH9.8 truncations allowed us to identify the IpaH9.8 LRR region that is required for the interaction with NEMO ( Supplementary Information, Fig. S3a, b) . As polyubiquitylation of NEMO, (Ub) n -NEMO, is required for the activation of the IKK complex and NF-κB in response to various stimuli 5, 6 , recombinant NEMO was incubated with E1, UbcH5b (as E2), ubiquitin (Ub) and GST-IpaH9.8 or GST-IpaH9.8CA, and NEMO was analysed for polyubiquitylation. IpaH9.8, but not IpaH9.8CA, was auto-ubiquitylated, and NEMO was ubiquitylated in the presence of IpaH9.8, but not IpaH9.8CA (Fig. 2b, left panel) . NEMO was also shown to be ubiquitylated in an IpaH9.8-dependent manner in 293T cells (Fig. 2b, right  panel) . Lys 63-linked ubiquitylation is sometimes required for signal transduction processes, including NF-κB activation, while Lys 48-linked ubiquitylation typically leads to proteasome degradation 22 . We therefore created a series of ubiquitin mutants possessing single lysine residues to investigate IpaH9.8-mediated NEMO ubiquitylation. NEMO was ubiquitylated by the Lys 27-Ub (K27-Ub) mutant to a similar extent as by wild-type ubiquitin (Fig. 2c, upper panel) . We then examined ubiquitin in which only one of each lysine residue had been replaced by arginine and confirmed that Lys 27 has a major role in the IpaH9.8-mediated ubiquitylation of NEMO (Fig. 2c, lower panel) . These findings suggest that IpaH9.8 is a bacterial ubiquitin E3 ligase that is capable of catalysing Lys 27-linked polyubiquitylation of NEMO.
To investigate the fate of ubiquitylated NEMO, we measured the halflife of NEMO in cells expressing, or not expressing, pFlag-IpaH9.8 or pFlag-IpaH9.8CA. NEMO levels in cells expressing IpaH9.8 decreased 3 h after cycloheximide treatment in comparison with cells expressing IpaH9.8CA. Intriguingly, the rate of IpaH9.8-mediated NEMO degradation was higher in Nod1-stimulated cells than in non-stimulated cells ( Supplementary Information, Fig. S4 ). Analysis of NEMO degradation kinetics in HeLa/pFlag-NEMO cells infected with Shigella (wild-type), S325 (TTSS-deficient mutant), ΔipaH9.8, ΔipaH9.8/pTB-ipaH9.8 (IpaH9.8 overproduction) or ΔipaH9.8/pTB-ipaH9.8CA (IpaH9.8CA overproduction) bacteria showed that NEMO levels had decreased to less than 20% of their original level by 4 h after infection with wild-type bacteria, but not after infection with S325 or ΔipaH9.8 bacteria. The effect on NEMO stability was greater in cells infected with ΔipaH9.8/ pTB-ipaH9.8 bacteria. NEMO levels were unchanged following infection with ΔipaH9.8/pTB-ipaH9.8CA bacteria (Fig. 2d) . As MG132 (a proteasome inhibitor), but not E64D plus pepstatin A (a lysosome inhibitor), prevented NEMO degradation in cells infected with Shigella/ pTB-ipaH9.8 (Fig. 2e) bacteria, we concluded that NEMO ubiquitylated by IpaH9.8 undergoes proteasomal degradation.
Previous studies found that the particular NEMO lysine residue that accepts ubiquitin depends on the stimulus; for example, T-cell receptor signalling triggers Lys 63-linked ubiquitylation of NEMO at Lys 399 (refs 23, 24) . MDP-induced Nod2-RICK stimulation triggers Lys 63-linked polyubiquitylation of NEMO at Lys 285, whereas LPS-induced TLR stimulation triggers Lys 285 and Lys 399 for ubiquitylation 25, 26 . LUBAC, a newly identified E3 ligase complex, triggers linear polyubiquitylation of NEMO at both Lys 285 and Lys 309 (ref. 27). We therefore tested a series of Flag-tagged truncations of NEMO for IpaH9.8-mediated ubiquitylation, by immunoprecipitation. The C-terminal portion (residues 296-322) was ubiquitylated (Fig. 3a) , and as three lysine residues are present in this part of the protein (Fig. 3b) (Fig. 3d) . As expected, the activity of Shigella-induced NF-κB was reduced by IpaH9.8 E3 ligase activity in Nemo -/-NEMO-wildtype cells but not in Nemo -/-NEMO K309R/K321R cells (Fig. 3e) . These results indicate that IpaH9.8 predominantly targets both the Lys 309 and Lys 321 residues of NEMO for ubiquitylation.
As ABIN-1 binds to NEMO and inhibits NF-κB activation by cooperating with A20, which mediates de-ubiquitylation of NEMO 19 , we performed a NF-κB reporter assay to determine the effect of ABIN-1 on Shigella-induced NF-κB activity. NF-κB activity in cells decreased in an ABIN-1 dose-dependent manner (Fig. 4b) , and IpaH9.8 strongly inhibited Shigella-induced NF-κB activity in control cells, but only weakly inhibited Shigella-induced NF-κB activity in ABIN-1 knockdown cells (Fig. 4c) . Furthermore, NEMO levels were reduced in control cells, but unaffected in ABIN-1 knockdown cells during ΔipaH9.8/pTB-ipaH9.8 infection, whereas NEMO levels were unaffected in both control and ABIN-1 knockdown cells during ΔipaH9.8/pTB-ipaH9.8CA infection (Fig. 4d) . These results indicate that the interaction between IpaH9.8 and ABIN-1 is involved in inhibition of NF-κB activity. To determine the role of ABIN-1 in IpaH9.8-mediated NF-κB inhibition, we investigated the ability of a series of truncations to interact with IpaH9.8. The results showed that ABIN-1 residues 351-367 were involved in interacting with IpaH9.8, and by using various IpaH9.8 truncations we were able to determine that the IpaH9.8 carboxy-terminal region is involved in the interaction with ABIN-1 ( Supplementary Information, Fig. S3c, d) .
To confirm ABIN-1 involvement in IpaH9.8-mediated NEMO ubiquitylation, we analysed the levels of ubiquitylated NEMO by immunoprecipitation. ABIN-1 promoted IpaH9.8-mediated NEMO ubiquitylation in a dose-dependent manner; however, ABIN-1 failed to induce NEMO ubiquitylation in the absence of IpaH9.8 (Fig. 4e) . Next, we assessed NEMO ubiquitylation in vitro (Fig. 4f) . NEMO was ubiquitylated in the presence of ubiquitin and GST-IpaH9.8 (lane 3), and when ABIN-1 was added to the reaction the extent of NEMO ubiquitylation increased in a dose-dependent manner (lanes 4-6), strongly suggesting that ABIN-1 does not possess E3 ubiquitin ligase activity, but rather acts as an adaptor for IpaH9.8-mediated ubiquitylation of NEMO.
In the A20-NEMO-ABIN-1 complex, ABIN-1 promotes the association between A20 and NEMO, thereby increasing A20-mediated NEMO deubiquitylation and inhibiting NF-κB activation 19 . Because this raises the possibility that ABIN-1 contributes to the association between IpaH9.8 and NEMO, we measured the amounts of ABIN-1 and IpaH9.8 that interacted with NEMO in lysates of cells expressing pGST-NEMO, pMyc-IpaH9.8CA and pHA-ABIN-1 or pHA-ABIN-1Δ, which lacks the IpaH9.8-binding domain but retains the NEMO-binding domain. Increased ABIN-1 levels enhanced the extent of interaction between IpaH9.8 and NEMO (Fig. 5a, left panel) , but increased ABIN-1Δ levels had little effect on the IpaH9.8-NEMO interaction (Fig. 5a, right panel) . Furthermore, an RNA interference (RNAi) experiment showed that the amount of NEMO protein bound to IpaH9.8 was lower in ABIN-1 knockdown cells (Fig. 5b) . These findings further support our proposal that ABIN-1 promotes IpaH9.8 binding to, and ubiquitylation of, NEMO.
Recent reports have indicated that ABIN-1 acts as a ubiquitin-binding protein [29] [30] [31] [32] . ABIN-1 interacts with NEMO through two domains. The C-terminal domain binds to NEMO, and the central AHD2 (ABIN homology domain 2) region is a ubiquitin-binding domain that interacts with ubiquitin moieties conjugated to NEMO 29 . We therefore investigated whether the ubiquitin-binding capacity of ABIN-1 that is required for interaction with NEMO is functionally involved in IpaH9.8-mediated downregulation of NF-κB activation, by creating an ABIN-1-ER/AA mutant (a ubiquitin-binding-deficient mutant) and testing its effect on NF-κB activation by TNF-α or Shigella. The results showed that ABIN-1 had an inhibitory effect on NF-κB activation by both TNF-α and Shigella, but that ABIN-1-ER/AA had no inhibitory effect on activation by either (Fig. 5c) , strongly suggesting that the interaction between ABIN-1 and NEMO through the polyubiquitin chain is pivotal to inhibition of NF-κB activation. Next, we investigated whether the ubiquitin-binding domain of ABIN-1 was involved in promoting the interaction between IpaH9.8 and polyubiquitnated-NEMO, which is stimulated through the Nod1 pathway. The results showed that ABIN-1-ER/AA interacted less strongly with IpaH9.8 and polyubiquitylated NEMO than ABIN-1-wild-type did (Fig. 5d) , suggesting that IpaH9.8 requires ABIN-1 as a ubiquitin-binding adaptor to promote its interaction with and ubiquitylation of NEMO.
To establish the role of IpaH9.8 E3 ligase activity in Shigella infection, we infected mice intranasally with a sublethal dose of wild-type, ΔipaH9. 8 Supplementary Information,  Fig. S6a) . Although evidence of a strong inflammatory response, such as suppurative masses, neutrophil infiltration and macrophage infiltration, was observed in the lungs infected with all of the bacterial strains, the inflammatory response to wild-type and ΔipaH9.8/ipaH9.8 strains eventually declined to a level similar to that in uninfected control lungs (saline), whereas the inflammatory response to ΔipaH9.8 and ΔipaH9.8/ipaH9.8CA strains persisted for 48 h ( Supplementary Information, Fig. S6b ). Consistent with these observations, the levels of tissue myeloperoxidase, MIP-2, IL-6 and IL-1β induced by ΔipaH9.8 and ΔipaH9.8/ipaH9.8CA strains were higher than the levels induced by wild-type and ΔipaH9.8/ipaH9.8 strains ( Supplementary  Information, Fig. S6c, d) .
Because numerous host sensors for bacterial components such as the TLR and NLR family, including the downstream signal pathways, are engaged in inducing and controlling the inflammatory response to bacterial infection, it is likely that large numbers of Shigella effectors, including IpaH9.8, are needed to modulate the various inflammatory signal pathways at different levels and times during bacterial infection of various host cells. In this study we showed that Shigella IpaH9.8 targets NEMO and ABIN-1, which results in the induction of Lys 27-mediated polyubiquitylation of NEMO, thereby facilitating the proteasomedependent degradation of NEMO and interfering with NF-κB activation during bacterial infection (Fig. 5e) . Although the reason is still unclear, the extent of NEMO degradation mediated by IpaH9.8 is more profound when Nod1 signalling is stimulated than TNF-α. Indeed, IpaH9.8-mediated inhibition of NF-κB activity is weaker in response to TNF-α than to stimulation by the Nod1 pathway (data not shown). Future studies will need to investigate the preferable NF-κB inhibition by IpaH9.8. The results of this study also demonstrate that the E3 ligase activity of IpaH9.8 contributes to promoting bacterial infection.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturecellbiology/.
Note: Supplementary Information is available on the Nature Cell Biology website.
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Strains and plasmids. Shigella flexneri strain YSH6000 was used as the wild type, and S325 (mxiA::Tn5) was used as a type III secretion system-deficient negative control. Construction of the non-polar mutant of ipaH9.8 of Shigella flexneri YSH6000 was carried out as described previously 33 . The pTB-101 vector (under the control of isopropyl-β-D-thiogalactopyranoside, IPTG, inducible ptac promoter) was used to construct the IpaH9.8-or IpaH9.8CA (the 337 th cystein residue was replaced by alanine)-overexpressing strains. The ipaH9.8-Flag or ipaH9.8CA-Flag were cloned into pTB-101, to yield pTB-ipaH9.8-Flag and pTB-ipaH9.8CA. The resultant plasmids were introduced into Shigella wild-type or ΔipaH9.8 strain. The pCACTUS-Tp suicide vector was used to construct the ipaH9.8 complement strains. The ipaH9.8 or ipaH9.8CA were cloned into pCACTUS, to yield pCACTUS-ipaH9.8 and pCAC-TUS-ipaH9.8CA. pCACTUS-ipaH9.8 and pCACTUS-ipaH9.8CA were integrated into the ipaH9.8 gene on the Shigella 220-kb plasmid creating ΔipaH9.8/ipaH9.8 and ΔipaH9.8/ipaH9.8CA strains. The ipaH9.8 or ipaH9.8CA coding sequence was amplified by PCR and cloned into pEGFP, pTB-101-Flag, pGEX-4T-1, pcDNAFlag, pcDNA-Myc 6 (6 × Myc), pcDL-SRα-Myc, pME-Flag or pME-HA vector. Human NEMO cDNA was amplified by RT-PCR from HeLa total mRNA and cloned into pEGFP, pGEX-4T-1, pGEX-6P-Flag, pME-GST, pcDNA-Myc 6 , or pcDNA-Flag vector. Human ABIN-1 cDNA was amplified by RT-PCR from HeLa total mRNA and cloned into pGEX-4T-1, pcDL-SRα-Myc or pME-HA vector. The E2s cDNA were subcloned into pGEX6P-1, pcDNA-HA or pcDNA-Myc vector. Site directed mutagenesis of ipaH9.8, NEMO or ABIN-1 was performed using QuickChange site directed mutagenesis kit (Stratagene). Cell culture. HeLa and 293T cells were cultured in Eagle's minimal essential medium (Sigma) and Dulbecco's modified Eagle medium (Sigma), respectively, containing 10% fetal calf serum. Stable HeLa cells expressing IpaH9.8 or control vector were selected with 1 mg ml -1 G418 (Roche) after transfection with pcDNA-Flag-IpaH9.8 or pcDNA vector. Wild-type and Nemo-deficient MEF cells were described previously 28 . To construct Nemo -/-cells stably expressing NEMOwild-type and NEMO
K309R/K321R
, cDNAs encoding these genes were subcloned into pMX-puro retroviral expression vectors. Retroviral supernatants were produced in Plat-E cells. Target cells were transduced with supernatants in the presence of DO-TAP (Roche), and then cloned under puromycin selection.
Bacterial infection. HeLa cells were infected with the different strains of Shigella, at a multiplicity of infection (MOI) of 100. In the case of the Shigella strains expressing afimbrial adhesin (Afa)-expressing strains, cells were infected at MOI = 10. Infection was initiated by centrifuging the plate at 700g for 10 min. After incubation for 15 min at 37°C, the plates were washed three times with PBS, transferred into fresh medium containing 100 μg ml -1 gentamicin and 60 μg ml
kanamycin to kill extracellular bacteria. In the case of IpaH9.8 (or IpaH9.8CA)-overexpressing experiments, 0.2 mM isopropyl-β-D-thiogalactopyranoside (IPTG) was added. After incubation for the indicated times, the cells were washed with PBS and collected using 2 × Laemmli sample buffer. Samples were subjected to western blotting. The density of each band was quantified by measuring the mean intensity with NIH image software version 1.63. The expression levels were normalized to the levels of β-actin.
Semi-quantitative RT-PCR analysis.
Total RNA was prepared with ISOGEN (Nippon gene), and cDNA was generated with Superscript II reverse transcriptase (Invitrogen) and amplified by PCR. Primer pairs were as follows; IL-8, 5´-ATGACTTCCAAGCTGGCCGTGGCT-3´ and 5´-TCTCAGCCCTCT-TCAAAAACTTCTC-3´; and GAPDH, 5´-CCACCCATGGCAAATTCCAT-GGCA-3´ and 5´-TCTAGACGGCAGGTCAGGTCCACC-3´. The density of each band was quantified by measuring mean intensity with NIH image software version 1.63. The expression levels were normalized to the levels of GAPDH.
Luciferase reporter assays. 293T cells were seeded in 24-well plates. After 24 h, cells were transfected with reporter plasmid (pNF-κB-Luc, pElK-1-luc, or pAP-1-Luc), Renilla luciferase constructs (phRL-TK; promega), and various combinations of expression plasmids using FuGENE6 transfection reagent (Roche). Total amounts of plasmid DNA were equalized using empty vector. After 24 h, cells were infected with Shigella wild-type (MOI = 30) or treated with TNF-α (10 ng ml -1 ) or LPS (100 ng ml -1 ) for 3 h. For investigating the MyD88 signalling pathway, TLR4 and MD2 expressing vectors were additionally transfected. Cell extracts were prepared and reporter activity was determined using the luciferase assay system (Promega). Results are presented as fold relative to the activity of uninfected or unstimulated cells. Data are representative of three independent experiments. NF-κB nuclear translocation. HeLa cells were transiently transfected with GFP-, GFP-IpaH9.8-or GFP-IpaH9.8CA-expressing plasmids. After 24 h, cells were infected with Shigella harbouring an Afa-expressing plasmid to induce NF-κB activation signalling. After infection for 1 h, cells were fixed and subjected to immunohistochemical staining using an anti-p65 antibody and TO-PRO3. To quantify the percentage of nuclear translocated p65, p65 co-localized with nuclear was determined by counting at least 300 GFP-, GFP-IpaH9.8-or GFPIpaH9.8CA-expressing cells using fluorescence microscopy. Cells infected with Shigella was also confirmed by observing the bacteria which invaded the cells with fluorescence microscopy.
Yeast two-hybrid screening. The yeast two-hybrid screen was performed with Matchmaker GAL4 Two-Hybrid System 3 (Clontech) or Pro-Quest (Invitrogen). The cDNA encoding full-length ipaH9.8 was cloned in-frame into the GAL-4 DNA binding domain vector pGBKT7 (Clontech) or pDB-Leu (Invitrogen). The resulting plasmid, pGBKT7-IpaH9.8 or pDB-Leu-IpaH9.8, was used as bait in yeast two-hybrid screening. Screening with a HeLa cDNA library (Clontech) or human brain cDNA library (Invitrogen) was performed according to the manufacturer's protocol.
Expression and purification of recombinant proteins. For GST fusion proteins, E. coli BL21 (DE3) strain harbouring pGEX4T-1 or pGEX-6P-1 derivatives were cultivated in L-broth supplemented with ampicillin (50 μg ml Pulldown assay. GST-NEMO or GST-ABIN-1 bound to glutathione Sepharose 4B beads was mixed with recombinant IpaH9.8-Flag for 2 h at 4 °C. After centrifugation, the beads were washed five times with 1% Triton X-100-PBS and subjected to western blotting.
Immunoprecipitation. 293T cells were transiently transfected using the calcium phosphate precipitation method. Cells were washed with PBS and lysed for 30 min at 4 °C in a lysis buffer containing 150 mM NaCl, 50 mM HEPES at pH7.5, 1 mM EDTA, 0.5% NP-40 and Complete protease inhibitor cocktail (Roche). Lysates were cleared by centrifugation and proteins were immunoprecipitated for 2 h with anti-GFP conjugated beads or anti-M2 Flag and Protein G beads (Sigma) at 4 °C. Immunoprecipitates were washed five times with lysis buffer and subjected to immunoblotting.
In vitro ubiquitylation assays. Autoubiquitylation assays were performed in 40 μl reaction mixture containing reaction buffer (25 mM Tris-HCl at pH 7.5, 50 mM NaCl, 5 mM ATP, 10 mM MgCl 2 and 0.1 mM DTT), 0.5 μg E1, 2 μg UbcH5b purified from E. coli as E2, and 2 μg ubiquitin purified from E. coli in the presence or absence of GST-IpaH9.8 or GST-IpaH9.8C337A. For in vitro NEMO ubiquitylation by IpaH9.8, reactions were performed as for autoubiquitylation assays except 1 μg recombinant NEMO was included. Reactions were incubated at 37 °C for 1 h and stopped by the addition of 5 × Laemmli sample buffer.
Immunoprecipitation (In vivo ubiquitylation assay). 293T cells were transfected as described above with the indicated constructs. Twelve hours before cell nature cell biology collection, cells were treated with MG132 (10 μM). Cells were collected, lysed in 1% SDS, followed by tenfold dilution with RIPA buffer (150 mM NaCl, 50 mM HEPES at pH 7.5, 1mM EDTA, 1% Triton X-100 and 0.1% SDS) and lysates were cleared by centrifugation as described above. Flag-NEMO was immunoprecipitated with anti-M2 Flag and Protein G beads. Samples were washed and prepared for western blot analysis.
Cycloheximide chase assay. 293T cells were treated with cycloheximide (25 μg ml -1
; Wako) at 24 h after transfection, then were collected at the indicated time. Nod1-dependent NF-κB activation was stimulated by transfection with pcDNA-Nod1 and iE-DAP (10 ng ml -1 ; (Invivogen). Samples were subjected to western blotting. The density of each band was quantified by measuring mean intensity with NIH image software version 1.63. The expression levels were normalized to the levels of β-actin.
RNAi. The human ABIN-1-specific siRNA sequence was as follows: 5´-CAGGAGAGCGUUACCAUGUGG-3´ and 5´-ACAUGGUAACGCUCUCC-UGAG-3´ (Sigma). Cells were transfected using RNAiMax (Invitrogen). After 72 h, siRNA-treated cells were used for further analysis.
Ubiquitin binding assay. 293T cells were transiently transfected with pME-GST-NEMO, pcDNA-Nod1 and pcDNA-HA-Ub (or empty vector) by a calcium phosphate precipitation method. After 36 h, cells were treated with iE-DAP (10 ng ml -1 ) to promote the Nod1-mediated polyubiquitylation of NEMO, and collected. The cell lysates were incubated with glutathione Sepharose 4B beads at 4 °C for 2 h. The beads were then washed five times with RIPA buffer. To examine the association between polyubiquitylated NENO and IpaH9.8 in the presence or absence of ABIN-1, GST-(Ub) n -NEMO Sepharose beads were incubated with Myc-IpaH9.8CA or HA-ABIN-1 (or HA-ABIN-1ER/AA) isolated from 293T cells for in vitro GST pulldown assay at 4 °C for 2 h. The beads were washed as described above, then subjected to western blotting.
Murine pneumonia model. Pulmonary infection was modelled in the mice as described previously 11 . Five-week-old female C57BL/6 mice (CREA Japan) were housed for a week in the animal facility of the Institute of Medical Science, University of Tokyo, in accordance with guidelines drafted by the university. S. flexneri were suspended in sterile saline, and 20 μl of the bacterial suspension was administered intranasally at 5 × 10 6 cfu. For histological analysis, mice were killed at the indicated time points after infection, and their lungs were removed and fixed in 4% paraformaldehyde in PBS. The tissue embedded was frozen in liquid nitrogen and sectioned with a Leica cryostat (model CM1900). The sections were stained with hematoxylin and eosin and examined under a microscope. Viable bacteria in the lung tissue were counted by culturing homogenized tissue for 18 h on LB agar plates. Each data point is the mean of the values for four infected mice in each group. MPO in the lung tissue was measured as described previously 
